Finch Therapeutics Group, Inc. - stock earnings
FNCH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.4 million USD | ? USD |
| 2023Q2 | -7.0 million USD | ? USD |
| 2023Q1 | -63.9 million USD | 107000 USD |
| 2022Q4 | -26.3 million USD | 8000 USD |
| 2022Q3 | -40.1 million USD | 138000 USD |
| 2022Q2 | -22.8 million USD | 361000 USD |
| 2022Q1 | -24.6 million USD | 354000 USD |
| 2021Q4 | -19.1 million USD | 806000 USD |
| 2021Q3 | -10.0 million USD | 11.3 million USD |
| 2021Q2 | -15.2 million USD | 2.8 million USD |
| 2021Q1 | -14.0 million USD | 3.6 million USD |
| 2020Q4 | -13.1 million USD | 1.8 million USD |
| 2020Q3 | -10.1 million USD | 1.8 million USD |
| 2020Q2 | -8.3 million USD | 2.3 million USD |
| 2020Q1 | -7.9 million USD | 1.8 million USD |
FNCH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -98.7 million USD | 115000 USD |
| 2022 | -113.7 million USD | 861000 USD |
| 2021 | -55.9 million USD | 18.5 million USD |
| 2020 | -39.2 million USD | 7.7 million USD |
| 2019 | -20.4 million USD | 10.2 million USD |
FNCH
Price: $2.32
52 week price:
Earnings Per Share: -46.59 USD
P/E Ratio: -0.04
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 136300
Market Capitalization: 3.3 million